Linden Invests in RQM+
Chicago, IL (August 16, 2021) – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today a majority investment in RQM+ Corp. (“RQM+” or the “Company”), a prior portfolio company of DFW Capital Partners, alongside the Company’s founders and management team. Headquartered in Monroeville, PA, RQM+ is one of the largest international providers of regulatory, quality, and compliance consulting services for the world’s leading medical device, in-vitro diagnostics, and combination product manufacturing companies.
Maria Fagan, CEO of RQM+, stated “We are extremely proud of the business we have built at RQM+ and are excited to partner with Linden to accelerate our growth and expand the breadth of services we can provide to our customers. We chose to partner with the Linden team because of their exclusive focus on healthcare investing and shared value creation plan for RQM+.”
Richard Thomas, incoming board member of RQM+ and industry veteran, added “We commend Maria Fagan, Lisa Casavant, and the entire management team at RQM+ on building an extraordinary business that provides superior quality and services essential to helping their clients navigate a dynamic and increasing complex regulatory landscape. As manufacturers accelerate product and technology innovation to meet future healthcare needs, RQM+ is uniquely positioned to support the industry with an expanding suite of end-to-end capabilities and strategic partnership approaches.”
Michael Farah, a Partner at Linden and incoming board member of RQM+, added “Our investment in RQM+ is a direct result of our dedicated and longstanding outsourced medical device services sector effort, and we are excited to partner with an organization with such a strong market reputation. We look forward to supporting the entire RQM+ team as they seek to grow both organically and through acquisitions.”
Kirkland & Ellis LLP served as legal advisor to Linden. Ice Miller LLP served as legal advisor to RQM+. Harris Williams LLC served as the exclusive financial advisor to RQM+. Twin Brook Capital Partners provided debt financing for the transaction.
RQM+ is a leading medical device and diagnostics focused, regulatory and quality consulting firm. The company delivers transformative solutions by providing an unrivaled collective expertise, fueled by passion for client success. RQM+’s experts are collaborative, laser-focused on client needs and committed to delivering high value solutions that exceed expectations. For more information, please visit www.rqmplus.com.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies. For more information, please visit www.lindenllc.com.